Back to search

Article

Exploring the Interaction of E3 Ubiquitin-Protein Ligase Parkin with Natural Compound Amentoflavone: Implications for Parkinson’s Disease Therapy

2024-01-23

Abstract excerpt

Parkinson's disease is a neurodegenerative disorder resulting from progressive damage to specific brain regions. Key symptoms encompass involuntary movements (tremor), slowness of movements (bradykinesia), and muscle rigidity. Although the precise cause remains uncertain, a combination of genetic and environmental factors is believed to contribute to its development. This study focuses on the interaction of the E3...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0db21539-289b-5651-b67b-c9fd408417b0
DOI
10.20944/preprints202401.1652.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the Interaction of E3 Ubiquitin-Protein Ligase Parkin with Natural Compound Amentoflavone: Implications for Parkinson’s Disease TherapyDOI 10.20944/preprints202401.1652.v1
Spondias mombin flavonoids showed super-binder ability with Downstream Molecular Targets of Parkinson’s Disease: Folkloric-therapy assessment as a Scaffold for Structural Studies in Neurodegenerative diseaseSemantic proximity
Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s DiseaseSemantic proximity
Molecular dynamic investigation for ROCO-4 kinase inhibitor as treatment options for parkinsonismSemantic proximity
Multi-Target Neuroprotective Mechanisms of Phenolic Compounds from Antiaris Africana against Parkinson's DiseaseSemantic proximity
Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.Semantic proximity
Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson diseaseSemantic proximity
GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson’s diseaseSemantic proximity
Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity.Semantic proximity
Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of USP30 and a framework for DUB ligandabilitySemantic proximity
Therapeutic potential of methylxanthine drug on alpha synuclein protein in Parkinson’s diseaseSemantic proximity
Targeting Mutant Phenylalanine Hydroxylase With Pyrimidine-Triazole Conjugates: A Primary Framework for Candidate Chaperone-Based Strategies in Phenylketonuria.Semantic proximity
Identification of Bile Acid-Derived Chemical Chaperone(s) Targeting E46K-Mutated Alpha-Synuclein Protein to Treat Parkinson's Disease: Molecular Modelling, Docking, ADME, and Simulation Studies.Semantic proximity
Select a neighboring publication to make it the new centre.